Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
Our deep pipeline and cash runway into 2030 enable IDEAYA to advance key combinations and to address multiple indications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback